CLINICAL_TRIALS
trial_result
· 2015-03-30
Clinical Trial Update: Study of IMOVAX POLIO® Subcutaneous as a Booster Vaccine in Pre-school Age Children in Japan [Phase 4]
Summary
A Phase 4 study of IMOVAX POLIO booster vaccine in pre-school children in Japan has completed with results posted in 2015.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Poliomyelitis, Polio | Phase 4 | Status: COMPLETED | Results posted: 2015-03-30